Results 161 to 170 of about 4,291 (203)

Combination of Omalizumab and Dupilumab for the Treatment of Severe Bullous Pemphigoid: a Series of 6 Cases. [PDF]

Acta Derm Venereol
Boisseau R, Scaramuzzino L, Bernard P, Bedane C, Fourmond S.   +4 more
europepmc   +1 more source

Bullous Pemphigoid-Associated S aureus Increases Protease Activity from Keratinocytes and Promotes Unique BP180 Cleavage. [PDF]

J Invest Dermatol
Hersom AM, Peterson LF, Schlievert PM, Pentland AP, Brewer MG.   +4 more
europepmc   +1 more source

Conjunctival Intraepithelial Neoplasia With IgG and Complement Deposition: Spurious Association or Biologically Explainable? [PDF]

Cureus
Zhang DD, Raja D, Cheung WL, Margo CE.
europepmc   +1 more source

Dupilumab in patients with bullous pemphigoid and concomitant atopy. [PDF]

Front Pharmacol
Jobst K, Künzel SR, Beissert S, Abraham S.   +3 more
europepmc   +1 more source

Ramipril-Induced Annular Bullous Pemphigoid: A Clinical Mimic of Linear IgA Dermatosis. [PDF]

Eurasian J Med
Karaca Ural Z.
europepmc   +1 more source

Generalised Bullous Pemphigoid Following Fasciotomy - A Rare Occurrence. [PDF]

Indian Dermatol Online J
Patnaik S, Panda DR, Subudhi A, Panda PK.   +3 more
europepmc   +1 more source

A Longitudinal Case Study of Recurrent Pyostomatitis-Pyodermatitis Vegetans Followed by the Subsequent Development of Bullous Pemphigoid With the Presence of Anti-BP230 Autoantibodies Six Years Later. [PDF]

Cureus
Ren Q, Liu Y, Wang J, Ren S, Guan X.
europepmc   +1 more source

A Single-Center Profile of Pemphigus in China: Significant Diagnostic Delay and Evolving Treatment Patterns. [PDF]

Clin Cosmet Investig Dermatol
Zhang H, Li D, Zhang Y, Lu X, Tang K, Zuo YG, Jin H.   +6 more
europepmc   +1 more source

The immunophenotype of immune checkpoint-induced bullous pemphigoid: a cohort study. [PDF]

Cancer Immunol Immunother
Saffuri N, Boyango I, Cohen I, Ali-Saleh Z, Dawood M, Khamaysi Z, Yogev D, Avitan-Hersh E.   +7 more
europepmc   +1 more source